Magazine article from our research archive:

Prospective, randomized comparison helps delineate MMS role in BCC treatment

Maastricht, The Netherlands - Available results from a prospective randomized study comparing Mohs' micrographie surgery (MMS) and surgical excision for facial basal cell carcinomas (BCCs) indicate MMS should be the treatment of choice for primary aggressive lesions and recurrent tumors, according to Nicole WJ. Smeets, M.D., Ph.D., department of dermatology, University Hospital, Maastricht and colleagues.

The study divided lesions into primary and recurrent groups, and within each of those categories, the tumors were randomized equally to surgical excision or MMS. Nearly 400 primary BCCs and about 200 recurrent tumors were treated.

Recurrence rate is being analyzed as the primary endpoint, ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!